To meet the demand of a growing patient-base, Green Relief Inc., a licensed producer of medical cannabis, has officially acquired possession of a new facility in Stoney Creek, Ont., that will significantly boost the company’s production capacity.

The 100,000-square-foot facility is located at 565 Seaman St., and is zoned commercial-industrial to accommodate cannabis production. Once the Stoney Creek site is at full capacity, Green Relief, which operates out of a 30,000-square-foot facility in the rural community of Flamborough, Ont., will increase its annual output from 2,800 kg to a total of about 17,800 kg.

“The acquisition of the Stoney Creek facility will allow our team to provide a growing number of medical cannabis patients with the products they need to improve their quality of life,” says Warren Bravo, Chief Executive Officer, Green Relief Inc. “As a bonus, the new facility will generate job growth, while also providing ancillary activities to drive the local economy.”

The Stoney Creek facility, which formerly housed a sporting complex, will require a $9-million retrofit to become operational in compliance with Health Canada regulations. To get the job done, Bravo says Green Relief is committed to sourcing Hamilton-based engineering firms and contractors.

Bravo anticipates the retrofit to commence in January 2019, with the facility up and running by March 2019, and a first harvest slated for mid-to-late summer.

As well as installing top technology for cannabis production, the Stoney Creek site will receive electrical upgrades, and be equipped with state-of-the-art security and HVAC systems. The latter will ensure cannabis production odours do not impact the surrounding neighbourhood.

In the coming months, Bravo says Green Relief will be hosting an on-site community event to address questions the public may have about the Stoney Creek facility, and introduce the neighbourhood to the company. This event will be coupled with a job fair to attract talent.

Once operational, the Stoney Creek facility will generate about 100 full-time jobs for the local workforce. Through Green Relief’s partnership with the Ontario Disability Employment Network, these roles will provide people of all abilities with meaningful work.

“Our growth in a rapidly developing sector means employment opportunities at the Stoney Creek facility will cover a range of roles, from frontline production technicians to environmental scientists, and everything in between,” Bravo says.

In addition to the Stoney Creek site, Green Relief’s expansion plans include construction of a 240,000-square-foot production facility at the company’s Flamborough site. A 25,000-square-foot facility on an adjacent property in Flamborough is also underway, and will be used for research and development.

Similar to Green Relief’s facility in Flamborough, which uses LED lights in its grow rooms and is earth-sheltered for efficiency, the Stoney Creek site will adopt the company’s sustainable production practices. This includes the use of aquaponics as a growing method.

Aquaponics combines aquaculture (raising fish) with hydroponics (the soilless cultivation of plants). The closed-loop system uses up to 90 per cent less water than conventional agriculture, while also producing 10 times the crop yield per hectare, and an end product free from synthetic fertilizers and harmful pesticides.

Moreover, once the system’s fish reach market size, Green Relief donates the protein source to Second Harvest, a food rescue service that delivers meals to those in need. Over the last three years, Green Relief has donated more than 40,000 fish through this initiative.

“At Green Relief, we do more than provide patients with safe and effective medical products to support their health and well-being,” Bravo says. “Creating jobs, being a good neighbour, and giving back to the community is at the heart of everything we do.”

About Green Relief

Based in Hamilton, Ont., Green Relief is Canada’s leading licensed producer of medical cannabis using aquaponics to sustainably grow its products. Green Relief’s mission is simple: helping patients improve their quality of life while also advancing the science behind medical cannabis through research that raises the profile of the plant’s many benefits. Green Relief is a privately held company with plans to go public in early 2019.

SOURCE Green Relief Inc.

For further information: Media contact, Email:, Facebook: @greenrelieflp, Twitter: @GreenReliefLP, Instagram: @greenrelieflp, LinkedIn: Green Relief


Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less